A phase IV, prospective, observational study of TNKase in patients enrolled in the national registry of myocardial infarction 4 and 5 (POST)

Trial Profile

A phase IV, prospective, observational study of TNKase in patients enrolled in the national registry of myocardial infarction 4 and 5 (POST)

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Feb 2017

At a glance

  • Drugs Tenecteplase (Primary)
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms POST
  • Sponsors Genentech
  • Most Recent Events

    • 20 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top